NH280105 / Jiangsu NHWA Pharma - LARVOL DELTA

A Study of NH280105 in Healthy Adult Participants (clinicaltrials.gov) - P1 | N=48 | Recruiting | Sponsor: Jiangsu Nhwa Pharmaceutical Co., Ltd. | Not yet recruiting ➔ Recruiting | Trial completion date: Oct 2025 ➔ Feb 2026 | Trial primary completion date: Oct 2025 ➔ Feb 2026

Enrollment open • Trial completion date • Trial primary completion date • Alzheimer's Disease • CNS Disorders